AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Top 36%
#1867 out of 5177 analysts
Average Return
+50.1%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +126.52% | $32.01 | $72.51 | 2025-06-10 - 2026-01-16 | Strong Buy |
Wave Life Sciences LtdWVE | +89.85% | $7.19 | $13.65 | 2025-06-10 - 2026-01-16 | Buy |
Disc Medicine IncIRON | +39.46% | $50.86 | $70.93 | 2025-06-10 - 2026-01-16 | Strong Buy |
Dyne Therapeutics IncDYN | +14.65% | $14.57 | $16.71 | 2025-06-10 - 2026-01-16 | Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +2.56% | Assumes | 7 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +304.26% | Reinstates | 7 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +121.49% | Assumes | 7 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +25.48% | Reinstates | 7 months ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $65.00 | -10.36% | Initiates Coverage On | 7 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.